Blood pressure pills taken by MILLIONS worldwide ‘raise your risk of lung cancer’, scientists warn
Other common names for the drugs include captopril, cilazapril and enalapri.
They work by reducing the activity of the angiotensin-converting enzyme, or ACE for short. By blocking this enzyme, the blood vessels relax and widen and blood pressure is lowered.
An estimated 103 million adults in the US, which is almost half the adult population, have high blood pressure, according to statistics this year from the American Heart Association.
The study, published in the BMJ, looked at 992,000 adults who were prescribed blood pressure drugs in the UK between 1995 and 2015.
Patients were taking one of two types of pills either ACE inhibitors or angiotensin receptor blockers, which work in a different way.
Compared to patients on the angiotensin receptor blockers, those on ACE inhibitors were 14 per cent more likely to be diagnosed with lung cancer over a six-year period.
The study was carried out by researchers at McGill University in Montreal, Quebec, in Canada, who called for ‘additional studies, with long term follow-up, to investigate the effects of these drugs on incidence of lung cancer’.